| P50 | author | Mohammad Reza Zinatizadeh | Q91940288 |
| P2093 | author name string | Mohammad Esmaeil Akbari | |
| | Hamid Reza Mirzaei | |
| | Ghanbar Mahmoodi Chalbatani | |
| | Hassan Dana | |
| | Seyed Rouhollah Miri | |
| | Seyed Ali Momeni | |
| | Peyman Kheirandish Zarandi | |
| P2860 | cites work | The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1 | Q24292345 |
| | Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation | Q24295079 |
| | Proapoptotic kinase MST2 coordinates signaling crosstalk between RASSF1A, Raf-1, and Akt | Q24296477 |
| | The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation | Q24297959 |
| | RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor | Q24301371 |
| | The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to Bax conformational change and cell death | Q24305092 |
| | Identification of Nore1 as a potential Ras effector | Q24314874 |
| | The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex | Q24323508 |
| | Role of the tumor suppressor RASSF2 in regulation of MST1 kinase activity | Q24336042 |
| | Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras | Q24338128 |
| | RASSF2 associates with and stabilizes the proapoptotic kinase MST2 | Q24338394 |
| | The Hippo Signaling Pathway in Development and Cancer | Q24603986 |
| | Nore1B regulates TCR signaling via Ras and Carma1 | Q24633118 |
| | RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein | Q24648062 |
| | Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis | Q28139203 |
| | The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas | Q28190533 |
| | Targeting RAS signalling pathways in cancer therapy | Q28201363 |
| | Identification of a novel Ras-regulated proapoptotic pathway | Q28203664 |
| | RASSF1A-LATS1 signalling stabilizes replication forks by restricting CDK2-mediated phosphorylation of BRCA2. | Q38956821 |
| | RASSF1A inactivation unleashes a tumor suppressor/oncogene cascade with context-dependent consequences on cell cycle progression | Q39004151 |
| | Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal | Q39108870 |
| | The RASSF3 candidate tumor suppressor induces apoptosis and G1-S cell-cycle arrest via p53. | Q39347028 |
| | ATM regulates a RASSF1A-dependent DNA damage response | Q39766802 |
| | Tumor suppressor Ras-association domain family 1 isoform A is a novel regulator of cardiac hypertrophy. | Q39817336 |
| | NORE1B is a putative tumor suppressor in hepatocarcinogenesis and may act via RASSF1A. | Q39899665 |
| | Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma. | Q40009864 |
| | Characterization of interactions of adapter protein RAPL/Nore1B with RAP GTPases and their role in T cell migration | Q40089954 |
| | Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways | Q40157708 |
| | RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. | Q40485735 |
| | Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma. | Q40514524 |
| | A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability | Q40543835 |
| | Proapoptotic Rassf1A/Mst1 signaling in cardiac fibroblasts is protective against pressure overload in mice | Q42416763 |
| | NORE1A tumor suppressor candidate modulates p21CIP1 via p53. | Q42799756 |
| | The cellular apoptosis susceptibility CAS/CSE1L gene protects ovarian cancer cells from death by suppressing RASSF1C. | Q44451511 |
| | Tumor susceptibility of Rassf1a knockout mice | Q45234570 |
| | RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. | Q45939520 |
| | A polymorphism at codon 133 of the tumor suppressor RASSF1A is associated with tumorous alteration of the breast. | Q46533945 |
| | Loss of Rassf1a enhances p53-mediated tumor predisposition and accelerates progression to aneuploidy | Q47603610 |
| | DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection | Q47753069 |
| | Nore1 inhibits tumor cell growth independent of Ras or the MST1/2 kinases | Q47984176 |
| | RASSF1A Suppresses Cell Migration through Inactivation of HDAC6 and Increase of Acetylated α-Tubulin | Q47986980 |
| | RASSF3 downregulation increases malignant phenotypes of non-small cell lung cancer. | Q50752468 |
| | Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. | Q53347351 |
| | Relationship of Ras association domain family 1 methylation and K-ras mutation in primary non-small cell lung cancer | Q53649603 |
| | RASSF1C, an Isoform of the Tumor Suppressor RASSF1A, Promotes the Accumulation of β-Catenin by Interacting with βTrCP | Q61824843 |
| | Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin | Q73735409 |
| | Recognizing and defining true Ras binding domains I: biochemical analysis | Q81643533 |
| | Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes | Q28265486 |
| | RASSF1A interacts with microtubule-associated proteins and modulates microtubule dynamics | Q28267593 |
| | NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma | Q28300321 |
| | RASSF6 is a novel member of the RASSF family of tumor suppressors | Q28509722 |
| | Mdm2 associates with Ras effector NORE1 to induce the degradation of oncoprotein HIPK1 | Q28592139 |
| | Acetylation: a regulatory modification to rival phosphorylation? | Q29614886 |
| | NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2. | Q30370843 |
| | A RASSF1A polymorphism restricts p53/p73 activation and associates with poor survival and accelerated age of onset of soft tissue sarcoma | Q30413809 |
| | The growth and tumor suppressors NORE1A and RASSF1A are targets for calpain-mediated proteolysis | Q30440607 |
| | Microtubule segment stabilization by RASSF1A is required for proper microtubule dynamics and Golgi integrity | Q30574008 |
| | RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers | Q33708522 |
| | The Ras effector RASSF2 controls the PAR-4 tumor suppressor | Q33877015 |
| | Genomic Profiling of Chronic Myelogenous Leukemia: Basic and Clinical Approach | Q33888064 |
| | Tumor Suppressor Ras Association Domain Family 5 (RASSF5/NORE1) Mediates Death Receptor Ligand-induced Apoptosis | Q34251431 |
| | Crucial functions of the Rap1 effector molecule RAPL in lymphocyte and dendritic cell trafficking | Q34347604 |
| | The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer | Q34433428 |
| | Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A. | Q34467504 |
| | The RASSF1A tumor suppressor activates Bax via MOAP-1. | Q34475337 |
| | Silencing of RASSF3 by DNA hypermethylation is associated with tumorigenesis in somatotroph adenomas | Q34650707 |
| | Novel gene targets detected by genomic profiling in a consecutive series of 126 adults with acute lymphoblastic leukemia | Q34798023 |
| | The RASSF1A tumor suppressor regulates XPA-mediated DNA repair | Q34968548 |
| | Death pathways triggered by activated Ras in cancer cells | Q34994888 |
| | Identification of candidate driver genes in common focal chromosomal aberrations of microsatellite stable colorectal cancer | Q35075615 |
| | Drugging the undruggable RAS: Mission possible? | Q35163434 |
| | EPB41L3, TSP-1 and RASSF2 as new clinically relevant prognostic biomarkers in diffuse gliomas. | Q35238478 |
| | Distinct structural domains within C19ORF5 support association with stabilized microtubules and mitochondrial aggregation and genome destruction | Q35576291 |
| | RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells | Q36216004 |
| | The RASSF1A tumor suppressor | Q36945316 |
| | The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naïve T cells. | Q37010249 |
| | Gene expression profiling of the 8q22-24 position in human breast cancer: TSPYL5, MTDH, ATAD2 and CCNE2 genes are implicated in oncogenesis, while WISP1 and EXT1 genes may predict a risk of metastasis | Q37407194 |
| | Alveolar rhabdomyosarcoma-associated PAX3-FOXO1 promotes tumorigenesis via Hippo pathway suppression | Q37410567 |
| | Functional single nucleotide polymorphisms of the RASSF3 gene and susceptibility to squamous cell carcinoma of the head and neck | Q37625248 |
| | Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells. | Q37761824 |
| | The Hippo pathway and human cancer. | Q38087215 |
| P433 | issue | 4 | |
| P304 | page(s) | 378-384 | |
| P577 | publication date | 2019-07-27 | |
| P1476 | title | The Role and Function of Ras-association domain family in Cancer: A Review | |
| P478 | volume | 6 | |